Intraoperative Radiation Therapy Market to Reach $66 Million by 2025 - A Comprehensive Report by MarketsandMarkets™
Ngày đăng: 22-11-2023 |
Ngày cập nhật: 22-11-2023
Intraoperative Radiation Therapy (IORT) market is an emerging segment within the broader radiation therapy market. IORT is a specialized form of radiation therapy that is delivered directly to a tumor site during surgery, immediately after the tumor is removed. This localized treatment aims to minimize radiation exposure to healthy surrounding tissues and organs, making it a potential option for certain cancer patients.
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083
The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. The rising incidence of cancer, technological advancements, and advantages offered by IORT are the major factors driving the growth of the global intraoperative radiation therapy market. Research and clinical trials are also being conducted to expand the applications of IORT; this will add to market growth prospects in the coming years.
The market for IORT was experiencing steady growth due to several factors, including:
Advancements in technology: Technological advancements in radiation delivery systems, imaging, and surgical techniques have made IORT more precise and accessible to a broader range of patients.
Increasing prevalence of cancer: The global incidence of cancer has been on the rise, leading to a growing patient pool for potential IORT treatments.
Rising demand for minimally invasive procedures: IORT offers the advantage of delivering a focused dose of radiation in a shorter timeframe, making it an attractive option for patients seeking less invasive treatment options.
Supportive clinical data: As more clinical evidence and research data become available, demonstrating the effectiveness and safety of IORT, its adoption has been on the rise.
Expanding healthcare infrastructure: Improvements in healthcare infrastructure and access to advanced medical facilities have contributed to the growth of the IORT market.
Growing awareness among healthcare professionals and patients: Increased awareness about IORT as a viable treatment option for specific cancer cases has led to greater adoption.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083
North America to dominate the intraoperative radiation therapy market during the forecast period
The Intraoperative radiation therapy products market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region is expected to account for the largest share of the market. The growth in this market is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of IORT products owing to the increasing incidence of cancer.
Key Market Players
The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=245000083
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=245000083
The global intraoperative radiation therapy market is projected to reach USD 66 million by 2025 from USD 48 million in 2020, at a CAGR of 6.4% during the forecast period. The rising incidence of cancer, technological advancements, and advantages offered by IORT are the major factors driving the growth of the global intraoperative radiation therapy market. Research and clinical trials are also being conducted to expand the applications of IORT; this will add to market growth prospects in the coming years.
The market for IORT was experiencing steady growth due to several factors, including:
Advancements in technology: Technological advancements in radiation delivery systems, imaging, and surgical techniques have made IORT more precise and accessible to a broader range of patients.
Increasing prevalence of cancer: The global incidence of cancer has been on the rise, leading to a growing patient pool for potential IORT treatments.
Rising demand for minimally invasive procedures: IORT offers the advantage of delivering a focused dose of radiation in a shorter timeframe, making it an attractive option for patients seeking less invasive treatment options.
Supportive clinical data: As more clinical evidence and research data become available, demonstrating the effectiveness and safety of IORT, its adoption has been on the rise.
Expanding healthcare infrastructure: Improvements in healthcare infrastructure and access to advanced medical facilities have contributed to the growth of the IORT market.
Growing awareness among healthcare professionals and patients: Increased awareness about IORT as a viable treatment option for specific cancer cases has led to greater adoption.
Request Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=245000083
North America to dominate the intraoperative radiation therapy market during the forecast period
The Intraoperative radiation therapy products market is segmented into five major regions, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. The North American region is expected to account for the largest share of the market. The growth in this market is mainly attributed to the increasing healthcare expenditure in the region, technological advancements, and high adoption of IORT products owing to the increasing incidence of cancer.
Key Market Players
The major players operating in the intraoperative radiation therapy market are ZEISS Group (Germany), iCAD, Inc. (US), Eckert & Ziegler (Germany), Elekta AB (Sweden), GMV Innovating Solutions (Spain), Sensus Healthcare, Inc. (US), IntraOp Medical, Inc. (US), Isoray, Inc. (US), Becton, Dickinson and Company (US), Sordina IORT Technologies (Italy), Varian Medical Systems, Inc. (US), SeeDos Ltd. (UK), IsoAid LLC (US), Ariane Medical Systems Ltd. (UK), Panacea Medical Technologies Pvt. Ltd. (India), Salutaris Medical Devices (US), Brainlab AG (Germany), RaySearch Laboratories (Sweden), REMEDI Co., Ltd. (South Korea), Merit Medical Systems, Inc. (US), among others.
Speak to Analyst: https://www.marketsandmarkets.com/speaktoanalystNew.asp?id=245000083
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies' revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets's flagship competitive intelligence and market research platform, "Knowledge Store" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA: +1-888-600-6441
Email: sales@marketsandmarkets.com
